Combined chromatin immunoprecipitation and next-generation sequencing (ChIP-seq) has become the gold standard to investigate genome-wide epigenetic profiles. However, ChIP from a limited amount of cells has been a challenge. Diagenode and Advanced Analytical Technologies, Inc. (AATI) provide the first complete and robust workflow solution for ChIP-seq from small numbers of cells using critical quality checkpoints to assure success. Download the application note.
The European Regional Development Fund and Wallonia are investing in your future.
Extension of industrial buildings and new laboratories.
